Signaling pathways
-
BA8747 PF-06843195Summary: PF-06843195 is a highly selective inhibitor. - BA8748 AZD8154Summary: AZD8154 is a novel inhaled selective dual inhibitor.
- BA8749 GSK-F1Summary: GSK-F1 is an orally active inhibitor.
- BA8750 VulolisibSummary: Vulolisib is a potent and orally active inhibitor.
- BA8751 SRX3207Summary: SRX3207 is an orally active, first-of-its-kind dual inhibitor.
- BA8752 PI4K-IN-1Summary: PI4K-IN-1 is a potent inhibitor.
- BA8753 IPI-3063Summary: IPI-3063 is a potent and selective inhibitor.
- BA8754 HL-8Summary: HL-8 is a molecule that targets kinases.
- BA8755 PI3Kα-IN-4Summary: PI3Kα-IN-4 is a potent, selective and orally active inhibitor.
- BA8756 NVS-PI3-4Summary: NVS-PI3-4 is a specific inhibitor.